miR-219 Cooperates with miR-338 in Myelination and Promotes Myelin Repair in the CNS
Central Nervous System
Mice, Knockout
0303 health sciences
Encephalomyelitis, Autoimmune, Experimental
Multiple Sclerosis
Membrane Proteins
Cell Differentiation
Nerve Tissue Proteins
Optic Nerve
Nerve Regeneration
Mice, Inbred C57BL
Disease Models, Animal
MicroRNAs
Oligodendroglia
03 medical and health sciences
Lecithins
Disease Progression
Animals
Cell Lineage
Gene Deletion
Myelin Sheath
Demyelinating Diseases
DOI:
10.1016/j.devcel.2017.03.001
Publication Date:
2017-03-27T19:40:04Z
AUTHORS (16)
ABSTRACT
A lack of sufficient oligodendrocyte myelination contributes to remyelination failure in demyelinating disorders. miRNAs have been implicated in oligodendrogenesis; however, their functions in myelin regeneration remained elusive. Through developmentally regulated targeted mutagenesis, we demonstrate that miR-219 alleles are critical for CNS myelination and remyelination after injury. Further deletion of miR-338 exacerbates the miR-219 mutant hypomyelination phenotype. Conversely, miR-219 overexpression promotes precocious oligodendrocyte maturation and regeneration processes in transgenic mice. Integrated transcriptome profiling and biotin-affinity miRNA pull-down approaches reveal stage-specific miR-219 targets in oligodendrocytes and further uncover a novel network for miR-219 targeting of differentiation inhibitors including Lingo1 and Etv5. Inhibition of Lingo1 and Etv5 partially rescues differentiation defects of miR-219-deficient oligodendrocyte precursors. Furthermore, miR-219 mimics enhance myelin restoration following lysolecithin-induced demyelination as well as experimental autoimmune encephalomyelitis, principal animal models of multiple sclerosis. Together, our findings identify context-specific miRNA-regulated checkpoints that control myelinogenesis and a therapeutic role for miR-219 in CNS myelin repair.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (55)
CITATIONS (138)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....